Novel Hemostatic Cardiac Risk Factors in Framingham

NCT00005356 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2016-02-18

No results posted yet for this study

Summary

To investigate hemostatic variables in relation to cardiovascular risk in the Framingham Offspring Study cohort.

Conditions

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    lead NIH

Principal Investigators

  • Geoffrey Tofler · Beth Israel Deaconess Medical Center

Eligibility

Max Age
100 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1994-07-31
Completion
1998-05-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00005356 on ClinicalTrials.gov